In February 2007 the company name was changed to XSpray to reflect the change in focus from research to commercialization of the technology for use in the production of high quality pharmaceutical particles. After achieving successful lab and scalability results, a decision was made in late 2007 to develop a GMP production facility.

In 2008, solid state characterization and analysis services were added to the company’s offering. 2008 also saw XSpray enter into its first commercial customer agreement. This was quickly followed by further customer agreements as the benefits of the technology became more widely recognized.

In 2009, XSpray doubled the size of its service lab and increased its personnel resources to meet growing interest in the company’s offering. XSpray’s GMP production facility was opened in mid 2009, providing customers with high quality drug particles and powders for use in their clinical studies.